ASND Stock Summary and Trading Ideas (Ascendis Pharma A/S - American Depositary Shares | NASDAQ:ASND)

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Ascendis Pharma A/S - American Depositary Shares trades on the NASDAQ stock market under the symbol ASND.

As of April 8, 2025, ASND stock price declined to $137.41 with 515,758 million shares trading.

ASND has a beta of 0.87, meaning it tends to be less sensitive to market movements. ASND has a correlation of 0.09 to the broad based SPY ETF.

ASND has a market cap of $8.26 billion. This is considered a Mid Cap stock.

Last quarter Ascendis Pharma A/S - American Depositary Shares reported $186 million in Revenue and -$.68 earnings per share. This beat revenue expectation by $63 million and exceeded earnings estimates by $.52.

In the last 3 years, ASND traded as high as $169.37 and as low as $61.58.

The top ETF exchange traded funds that ASND belongs to (by Net Assets): IBB, TCAF, MSSM, SPDW, FDG.

ASND has underperformed the market in the last year with a price return of -8.3% while the SPY ETF lost -2.9%. However, in the short term, ASND had mixed performance relative to the market. It has outperformed in the last 3 months, returning +0.1% vs -15.4% return in SPY. But in the last 2 weeks, ASND shares have been beat by the market, returning -18.2% compared to an SPY return of -13.5%.

ASND support price is $135.13 and resistance is $145.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASND shares will trade within this expected range on the day.